These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16167015

  • 21. Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG).
    Lazarus HM, Vogelsang GB, Rowe JM.
    Bone Marrow Transplant; 1997 Mar; 19(6):577-600. PubMed ID: 9085738
    [Abstract] [Full Text] [Related]

  • 22. Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation.
    Mohty M, Gaugler B.
    Cytokine Growth Factor Rev; 2008 Feb; 19(1):53-63. PubMed ID: 18083060
    [Abstract] [Full Text] [Related]

  • 23. Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease.
    Maeda Y, Tawara I, Teshima T, Liu C, Hashimoto D, Matsuoka K, Tanimoto M, Reddy P.
    Exp Hematol; 2007 Feb; 35(2):274-86. PubMed ID: 17258076
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C, Sakamaki H, Sao H, Mori S, Okamoto S, Miyamura K, Kato S, Kawase T, Morishima Y, Kodera Y, Japan Marrow Donor Program.
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Characteristics and functions of inflammatory cells isolated from acute graft-versus-host disease target organs after bone marrow transplantation in the rat.
    Renkonen R, Leszczynski D, Wangel A, Häyry P.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2689. PubMed ID: 3274579
    [No Abstract] [Full Text] [Related]

  • 28. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
    Auletta JJ, Cooke KR.
    Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.
    Fukui J, Inaba M, Ueda Y, Miyake T, Hosaka N, Kwon AH, Sakaguchi Y, Tsuda M, Omae M, Kamiyama Y, Ikehara S.
    Stem Cells; 2007 Jun; 25(6):1595-601. PubMed ID: 17446564
    [Abstract] [Full Text] [Related]

  • 33. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
    Georgantas RW, Bohana-Kashtan O, Civin CI.
    Transplantation; 2006 Aug 27; 82(4):471-8. PubMed ID: 16926590
    [Abstract] [Full Text] [Related]

  • 34. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
    Iori AP, Torelli GF, De Propris MS, Milano F, Pupella S, Gozzer M, Mancini F, Milani ML, Intoppa S, Cerretti R, Lucarelli B, Valle V, Malandruccolo L, Iannella E, Arleo E, Guarini A, Foà R.
    Transplantation; 2008 Feb 15; 85(3):386-90. PubMed ID: 18322430
    [Abstract] [Full Text] [Related]

  • 35. Vasoactive intestinal polypeptide induces regulatory dendritic cells that prevent acute graft versus host disease and leukemia relapse after bone marrow transplantation.
    Delgado M, Chorny A, Ganea D, Gonzalez-Rey E.
    Ann N Y Acad Sci; 2006 Jul 15; 1070():226-32. PubMed ID: 16888171
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease.
    Hashimoto D, Asakura S, Matsuoka K, Sakoda Y, Koyama M, Aoyama K, Tanimoto M, Teshima T.
    Eur J Immunol; 2007 Jan 15; 37(1):271-81. PubMed ID: 17154260
    [Abstract] [Full Text] [Related]

  • 38. [Immunosuppressive drugs in the prevention and treatment of GVHD after allogenic bone marrow transplantation].
    Basić-Jukić N, Labar B.
    Acta Med Croatica; 2003 Jan 15; 57(2):131-9. PubMed ID: 12879693
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.